Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
Journal of Medical Economics
|
May 13, 2016
A cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UK
Gorden Muduma, Isaac Odeyemi, Richard F Pollock
Expert Opinion on Drug Delivery
|
January 24, 2015
An analysis of product wastage arising from dosing increment granularity in four modern growth hormone administration devices
Richard F Pollock, Anne-Marie Kappelgaard, Lisa Seitz
Advances in Therapy
|
September 18, 2024
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
Fengkui Zhang, Aizong Shen, Waqas Ahmed, et al.
Advances in Therapy
|
September 13, 2023
Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled Trials
Seiji Fukumoto, Tatsunori Murata, Yutaka Osuga, et al.
Journal of Medical Economics
|
March 15, 2012
A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States
Richard F Pollock, Bradley H Curtis, William J Valentine
Plos One
|
November 5, 2016
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant
Gorden Muduma, Rhodri Saunders, Isaac Odeyemi, et al.
Advances in Therapy
|
February 25, 2016
Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients
Gorden Muduma, Isaac Odeyemi, Jayne Smith-Palmer, et al.
Expert Review of Anticancer Therapy
|
November 2, 2020
A systematic literature review and network meta-analysis of first-line treatments for unresectable hepatocellular carcinoma based on data from randomized controlled trials
Richard F Pollock, Victoria K Brennan, Suki Shergill, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
May 31, 2018
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
Richard F Pollock, Barrie Chubb, William J Valentine, et al.
Patient Preference and Adherence
|
April 15, 2014
Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence
Gorden Muduma, Isaac Odeyemi, Jayne Smith-Palmer, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
Journal of Medical Economics
|
May 13, 2016
A cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UK
Gorden Muduma, Isaac Odeyemi, Richard F Pollock
Expert Opinion on Drug Delivery
|
January 24, 2015
An analysis of product wastage arising from dosing increment granularity in four modern growth hormone administration devices
Richard F Pollock, Anne-Marie Kappelgaard, Lisa Seitz
Advances in Therapy
|
September 18, 2024
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
Fengkui Zhang, Aizong Shen, Waqas Ahmed, et al.
Advances in Therapy
|
September 13, 2023
Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled Trials
Seiji Fukumoto, Tatsunori Murata, Yutaka Osuga, et al.
Journal of Medical Economics
|
March 15, 2012
A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States
Richard F Pollock, Bradley H Curtis, William J Valentine
Plos One
|
November 5, 2016
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant
Gorden Muduma, Rhodri Saunders, Isaac Odeyemi, et al.
Advances in Therapy
|
February 25, 2016
Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients
Gorden Muduma, Isaac Odeyemi, Jayne Smith-Palmer, et al.
Expert Review of Anticancer Therapy
|
November 2, 2020
A systematic literature review and network meta-analysis of first-line treatments for unresectable hepatocellular carcinoma based on data from randomized controlled trials
Richard F Pollock, Victoria K Brennan, Suki Shergill, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
May 31, 2018
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
Richard F Pollock, Barrie Chubb, William J Valentine, et al.
Patient Preference and Adherence
|
April 15, 2014
Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence
Gorden Muduma, Isaac Odeyemi, Jayne Smith-Palmer, et al.
Page
of 9